SCHEMBL27826601

SCHEMBL27826601

COC(=O)c1c(-c2ccccc2)ccc([N+](=O)[O-])c1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.45
▸ ALDH1A1 P00352 6/20 0.44
▸ TDP1 Q9NUW8 2/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ PRKCZ Q05513 1/20 0.44
▸ GABRA1 P14867 1/20 0.43
▸ GABRG2 P18507 1/20 0.43
▸ GABRB3 P28472 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ GABRA3 P34903 1/20 0.43
▸ MAPT P10636 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ABCC4 O15439 1/20 0.42
▸ PLIN1 O60240 1/20 0.42
▸ CACNA1F O60840 1/20 0.42
▸ GMNN O75496 1/20 0.42
▸ KCNK2 O95069 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1984350 0.84 ALDH1A1 (0.50) ALDH1A1TDP1KMT2AMEN1MAPT
SCHEMBL29192912 0.80 HTT (0.44) HTTALDH1A1TDP1KMT2ALMNA
SCHEMBL29766208 0.79 HTT (0.54) HTTALDH1A1TDP1KMT2ALMNA
SCHEMBL28808729 0.79 HTT (0.54) HTTALDH1A1TDP1KMT2ALMNA
SCHEMBL28863790 0.77 HTT (0.49) HTTALDH1A1TDP1KMT2ALMNA
SCHEMBL29944963 0.77 HTT (0.49) HTTALDH1A1TDP1KMT2ALMNA
SCHEMBL15727851 0.77 SMN1; SMN2 (0.41) HTTALDH1A1TDP1KMT2ALMNA
SCHEMBL13228930 0.77 HTT (0.62) HTTALDH1A1TDP1KMT2ALMNA
SCHEMBL2484847 0.75 VCAM1 (0.57) ALDH1A1TDP1KMT2ALMNAHPGD
SCHEMBL6340501 0.75 MEN1 (0.54) HTTALDH1A1KMT2AMEN1PRKCZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102227436-A Macrocyclic compounds as hepatitis c virus inhibitors BRISTOL MYERS SQUIBB CO 2011-10-26 — — CN disclosed
Send feedback